Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting

Of the 28 million population of Punjab (2011 Census), 3.6% are estimated to be positive for anti HCV antibody and 2.6% (728,000) are estimated to test positive for HCV RNA.[1,2] A majority of these people may progress to cirrhosis and its complications including variceal bleeding, liver failure and hepatocellular carcinoma (HCC), or death.[3,4] Successful treatment of chronic hepatitis C (CHC) is associated with 62-84% reduction in all-cause mortality, 68-79% reduction in risk of HCC and 90% reduction in need for liver transplantation.

Source: Journal of Hepatology - July 16, 2019 Category: Gastroenterology Authors: Radha K. Dhiman, Gagandeep S. Grover, Madhumita Premkumar, Sunil Taneja, Ajay Duseja, Sanjeev Arora, Sahaj Rathi, Sandeep Satsangi, Akash Roy, MMPHCRF Investigators Source Type: research